Yongwei Su

973 total citations
27 papers, 688 citations indexed

About

Yongwei Su is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Yongwei Su has authored 27 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 16 papers in Hematology and 6 papers in Oncology. Recurrent topics in Yongwei Su's work include Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (8 papers). Yongwei Su is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (11 papers) and Protein Degradation and Inhibitors (8 papers). Yongwei Su collaborates with scholars based in China, United States and Saint Kitts and Nevis. Yongwei Su's co-authors include Yubin Ge, Jeffrey W. Taub, Holly Edwards, Hai Lin, Hui Qi, Danping Liu, Jay Yang, Guan Wang, Maik Hüttemann and Xinyu Li and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Yongwei Su

23 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongwei Su China 13 563 302 129 86 82 27 688
Na Luo China 13 373 0.7× 262 0.9× 180 1.4× 115 1.3× 96 1.2× 22 715
Cristina Panuzzo Italy 15 401 0.7× 316 1.0× 91 0.7× 122 1.4× 171 2.1× 49 644
Hiroe Amou Japan 11 319 0.6× 251 0.8× 126 1.0× 301 3.5× 25 0.3× 16 633
Weihong Zhang China 9 356 0.6× 116 0.4× 91 0.7× 102 1.2× 37 0.5× 12 476
Annamaria Petrungaro Italy 9 284 0.5× 74 0.2× 226 1.8× 58 0.7× 75 0.9× 13 456
Daniele Derudas Italy 9 369 0.7× 494 1.6× 47 0.4× 258 3.0× 127 1.5× 30 624
Ting‐juan Zhang China 18 712 1.3× 388 1.3× 320 2.5× 86 1.0× 61 0.7× 63 868
Galit Granot Israel 13 290 0.5× 206 0.7× 147 1.1× 83 1.0× 103 1.3× 28 503
Xiaoman Jung United States 7 309 0.5× 163 0.5× 184 1.4× 160 1.9× 75 0.9× 8 574
Chelsia Qiuxia Wang Singapore 12 228 0.4× 142 0.5× 39 0.3× 87 1.0× 98 1.2× 19 451

Countries citing papers authored by Yongwei Su

Since Specialization
Citations

This map shows the geographic impact of Yongwei Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwei Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwei Su more than expected).

Fields of papers citing papers by Yongwei Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwei Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwei Su. The network helps show where Yongwei Su may publish in the future.

Co-authorship network of co-authors of Yongwei Su

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwei Su. A scholar is included among the top collaborators of Yongwei Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwei Su. Yongwei Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carter, Jenna L., Yongwei Su, Jianlei Zhao, et al.. (2025). ONC213: a novel strategy to resensitize resistant AML cells to venetoclax through induction of mitochondrial stress. Journal of Experimental & Clinical Cancer Research. 44(1). 10–10.
2.
Yang, Yang, et al.. (2025). Arthroscopic and Open Surgery Show Comparable Efficacy in the Treatment of Lateral Epicondylitis: A Systematic Review. Arthroscopy The Journal of Arthroscopic and Related Surgery.
3.
4.
5.
Carter, Jenna L., Yongwei Su, Jianlei Zhao, et al.. (2023). Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms. Biochemical Pharmacology. 216. 115759–115759. 9 indexed citations
6.
Liu, Shuang, Yongwei Su, Holly Edwards, et al.. (2022). c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia. APOPTOSIS. 27(11-12). 913–928. 16 indexed citations
7.
8.
Li, Xinyu, Yongwei Su, Jenna L. Carter, et al.. (2022). Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia. Biochemical Pharmacology. 205. 115283–115283. 11 indexed citations
9.
Ma, Jun, Tristan Knight, Yongwei Su, et al.. (2021). The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer Journal. 11(6). 111–111. 27 indexed citations
10.
Liu, Fangbing, Yongwei Su, Jing Lv, et al.. (2021). Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance. Experimental Hematology. 105. 39–49. 13 indexed citations
11.
Su, Yongwei, et al.. (2021). Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model. Life Sciences. 272. 119208–119208. 35 indexed citations
12.
Carter, Jenna L., Jay Yang, Hasini A. Kalpage, et al.. (2020). Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduction and Targeted Therapy. 5(1). 288–288. 143 indexed citations
13.
Luedtke, Daniel A, Yongwei Su, Jun Ma, et al.. (2020). Inhibition of CDK9 by voruciclib synergistically enhances cell death induced by the Bcl-2 selective inhibitor venetoclax in preclinical models of acute myeloid leukemia. Signal Transduction and Targeted Therapy. 5(1). 17–17. 50 indexed citations
14.
Liu, Fangbing, Hasini A. Kalpage, Holly Edwards, et al.. (2020). Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation. Cancers. 12(9). 2400–2400. 29 indexed citations
15.
Li, Xinyu, Yongwei Su, Gerard J. Madlambayan, et al.. (2020). The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia. Haematologica. 106(5). 1262–1277. 38 indexed citations
16.
Qi, Hui, et al.. (2019). Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways. In Vitro Cellular & Developmental Biology - Animal. 55(3). 203–210. 110 indexed citations
17.
Liu, Fangbing, Tristan Knight, Yongwei Su, et al.. (2019). Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex Vivo. Targeted Oncology. 14(3). 351–364. 5 indexed citations
18.
Luedtke, Daniel A, Yongwei Su, Shuang Liu, et al.. (2018). Inhibition of XPO1 enhances cell death induced by ABT‐199 in acute myeloid leukaemia via Mcl‐1. Journal of Cellular and Molecular Medicine. 22(12). 6099–6111. 46 indexed citations
19.
20.
Su, Yongwei, Xinyu Li, Jun Ma, et al.. (2017). Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochemical Pharmacology. 148. 13–26. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Na Luo Breakdown of academic impact, for papers by Cristina Panuzzo Breakdown of academic impact, for papers by Hiroe Amou Breakdown of academic impact, for papers by Weihong Zhang Breakdown of academic impact, for papers by Annamaria Petrungaro Breakdown of academic impact, for papers by Daniele Derudas Breakdown of academic impact, for papers by Ting‐juan Zhang Breakdown of academic impact, for papers by Galit Granot Breakdown of academic impact, for papers by Xiaoman Jung Breakdown of academic impact, for papers by Chelsia Qiuxia Wang
Rankless by CCL
2026